Progressive multifocal leukoencephalopathy

S Zhai, BJ Brew - Handbook of clinical neurology, 2018 - Elsevier
Progressive multifocal leukoencephalopathy (PML) is a relatively common complication of
HIV disease. In this chapter changes to the epidemiology are discussed along with an …

Progressive multifocal leukoencephalopathy and rheumatoid arthritis treatments

G Clavel, A Moulignier, L Semerano - Joint Bone Spine, 2017 - Elsevier
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central
nervous system due to reactivation of the JC virus (JCV). PML is extremely uncommon …

Nationwide laboratory surveillance of progressive multifocal leukoencephalopathy in Japan: fiscal years 2011–2020

K Nakamichi, Y Miura, T Shimokawa, K Takahashi… - Viruses, 2023 - mdpi.com
Progressive multifocal leukoencephalopathy (PML) is a devastating demyelinating disease
caused by JC virus (JCV), predominantly affecting patients with impaired cellular immunity …

Progressive multi-focal leucoencephalopathy–driven from rarity to clinical mainstream by iatrogenic immunodeficiency

SA Misbah - Clinical & Experimental Immunology, 2017 - academic.oup.com
Advances in immune-mediated targeted therapies have proved to be a double-edged sword
for patients by highlighting the risk of iatrogenic infective complications. This has been …

JC polyomavirus infection potentiated by biologics

A Multani, DY Ho - Infectious Disease Clinics, 2020 - id.theclinics.com
JC polyomavirus (JCPyV) is a human polyomavirus that was first identified in 1971 as the
cause of progressive multifocal leukoencephalopathy (PML) in the brain of John …

Analysis of drug-induced posterior reversible encephalopathy syndrome using the food and drug administration adverse drug events reporting system database

CL Lei, XL Gui, LY Wang, YJ Guo… - Expert Opinion on Drug …, 2024 - Taylor & Francis
Objective In this retrospective pharmacovigilance study, we gathered data on drug-induced
posterior reversible encephalopathy syndrome (PRES). Our goal was to identify the primary …

Progressive multifocal leukoencephalopathy in HIV-uninfected individuals

D Saylor, A Venkatesan - Current infectious disease reports, 2016 - Springer
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central
nervous system (CNS) caused by the human neurotropic polyomavirus JC (JCV). The …

Drug‐induced progressive multifocal leukoencephalopathy: a case/noncase study in the French pharmacovigilance database

O Colin, S Favrelière, A Quillet, JP Neau… - Fundamental & …, 2017 - Wiley Online Library
Progressive multifocal leukoencephalopathy (PML) is an often fatal demyelinating disease
of the central nervous system. As effective treatment is unavailable, identification of all drugs …

[HTML][HTML] Progressive multifocal leukoencephalopathy in a lung transplant recipient

J Sakizadeh, MJ Davis, L Fontana - Clinical Case Reports, 2024 - ncbi.nlm.nih.gov
PML was first characterized in 1958 as a severe demyelinating infectious process caused by
the reactivation of the polyomavirus known as JC virus. 1, 2 Typically in immunocompetent …

我国药源性进行性多灶性白质脑病的风险认知分析

冯红云, 范燕, 吴桂芝, 董铎 - 中国药物警戒, 2016 - zgywjj.magtechjournal.com
目的了解我国关于药源性进行性多灶性白质脑病(PML) 的风险认知水平, 为临床正确认识及合理
防治药源性PML 提供参考. 方法对国内外文献数据库, 世界卫生组织药品不良反应监测数据库 …